The Issuer is currently preparing its submission to be dually listed on the Canadian Venture Exchange.
All shareholders that have paid for their shares in Evergreen-Agra, Inc. (US) will receive on a 1:1 basis dividend shares in the Canadian Company.
The Issuer will also be applying for a listing on the Frankfurt Exchange, no dividend shares will be issued on this listing.
The Issuer over the next 90 days and onwards will be announcing the assets it will be vending into Evergreen-Agra, Inc.
The Issuer will be taking a an aggressive posture within the sector with the ramping up of its operations.
The Issuer has chosen this strategy due to the progressive nature of Canadian Law in the Sector.
The Issuer is in the final phases of its research, development and initial beta testing of “True Synthetics”. The Synthetics are to include and notwithstanding Cannabis, CBD Oils, Rubs and THC, further insight into our developments will be disseminated as material events are achieved and presented for FDA and Health Canada review and approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.